New device in use at Spohn Shoreline helps take load off patients' hearts recover from cardiac episodes
It's a medical device that is already being put to good use, with the Shoreline team having already implanted the device in a ...
Medscape12d
Impella LP2.5 vs. IABP in Cardiogenic SHOCK (ISAR-SHOCK)
The Impella group required transfusion of 2.6 U packed red blood cells versus 1.2 U in the IABP group (p = 0.18). Among patients with cardiogenic shock due to AMI, the Impella device resulted in a ...
TCTMD4y
Contemporary Look at the Treatment of Cardiogenic Shock with Impella
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
GoodNewsNetwork8d
World’s Smallest Heart Pump ‘A Game-changer’ in Keeping Failing Hearts Going Without Major Surgery
For 5 weeks, the tiny Impella kept Katrina Penney's failed heart pumping while a second heart transplant was secured.
Medscape4d
Cardiogenic Shock: A Summary of the Randomized SHOCK Trial
Cardiogenic shock is the most common cause of death for patients hospitalized with acute myocardial infarction. The Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock ...
Too Old to Operate7d
Corticosteroid Administration and Mortality in Cardiogenic Shock
The following is a summary of “Corticosteroids in Cardiogenic Shock: A Retrospective Analysis of the Medical Information Mart ...
PharmiWeb3d
Key Innovations Driving Growth in the Cardiogenic Shock Treatment Market
Explore the latest innovations in cardiogenic shock treatment, including advances in mechanical circulatory support devices, ...
Simple risk score model could help with weaning patients from mechanical circulatory support
Patients with severe heart failure or cardiogenic shock often require assistance from MCS devices such as venoarterial ...